Covidien Closes In On Varicose Vein Market With $440 Mil. VNUS Buy
Covidien will bolster its vascular business through the acquisition of varicose vein treatment marketer VNUS for $440 million
Covidien will bolster its vascular business through the acquisition of varicose vein treatment marketer VNUS for $440 million